2 In addition to lifestyle modifications (diet and exercise), many pharmacologic strategies have been proposed to counter iatrogenic weight gain, including appetite suppressants (eg, pro-dopaminergic agents such as phentermine, stimulants, and amantadine), pro-anorectant anticonvulsants (eg, topiramate or zonisamide), opioid receptor antagonists (eg, olanzapine/samidorphan or naltrexone) and oral hypoglycemics such as metformin
F., Queiroz, V
Side effects Generally well-tolerated
Most patients notice appetite reduction within the first 12 weeks of starting GLP-1 medication
Tissue-Specific Expression of the Human Receptor for Glucagon-Like Peptide-I: Brain, Heart and Pancreatic Forms Have the Same Deduced Amino Acid Sequences
Lab Tests for Kidney Function BUN Blood urea nitrogen (BUN) and Carbon Dioxide (CO2) constitute the final product of protein metabolism